Get the Stockscreener App
0.4416
0.43%
-0.0019
Harvard Bioscience Inc stock is traded at $0.4416, with a volume of 291.69K.
It is down -0.43% in the last 24 hours and down -8.48% over the past month.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
See More
Previous Close:
$0.4435
Open:
$0.4355
24h Volume:
291.69K
Relative Volume:
0.33
Market Cap:
$19.66M
Revenue:
$106.79M
Net Income/Loss:
$-8.73M
P/E Ratio:
-2.208
EPS:
-0.2
Net Cash Flow:
$10.81M
1W Performance:
-7.65%
1M Performance:
-8.48%
6M Performance:
-35.53%
1Y Performance:
-84.17%
1-Day Range:
$0.43
$0.4559
1-Week Range:
$0.43
$0.4826
52-Week Range:
$0.2813
$3.04
Harvard Bioscience Inc Stock (HBIO) Company Profile
Name
Harvard Bioscience Inc
Sector
Industry
Phone
(508) 893-8999
Address
84 OCTOBER HILL RD, HOLLISTON, MA
Compare HBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.4416 | 19.99M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
449.68 | 161.31B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
186.84 | 54.01B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
270.14 | 39.60B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
78.29 | 38.49B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
253.50 | 18.35B | 2.96B | 487.70M | 344.00M | 6.68 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Mar-10-23 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Jan-07-21 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-09-20 | Initiated | Northland Capital | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-08-19 | Downgrade | Janney | Buy → Neutral |
| Jan-24-18 | Reiterated | Janney | Buy |
| Jan-23-18 | Reiterated | The Benchmark Company | Buy |
| Nov-17-16 | Initiated | Singular Research | Buy |
| Jul-28-15 | Initiated | The Benchmark Company | Buy |
View All
Harvard Bioscience Inc Stock (HBIO) Latest News
Harvard Bioscience stock price target lowered to $2 at Benchmark - Investing.com
Resilient Performance and Strategic Growth Drive Buy Rating for Harvard Bioscience Amid Market Challenges - TipRanks
Harvard Bioscience Appoints Stephen DeNelsky to Board - MSN
Harvard Bioscience appoints Stephen DeNelsky to board of directors By Investing.com - Investing.com South Africa
Harvard Bioscience appoints Stephen Denelsky to board - MarketScreener
Harvard Bioscience appoints Stephen DeNelsky to board of directors - Investing.com
Harvard Bioscience, Inc. Appoints Stephen DeNelsky to Board of Directors - Quiver Quantitative
Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors - GlobeNewswire
Healthcare Finance Expert with 30-Year Track Record: Harvard Bioscience Adds Oaktree MD to Board - Stock Titan
Live Scanner Shows Breakout on Harvard Bioscience Inc.Earnings Recap Report & Community Supported Trade Ideas - beatles.ru
Does Harvard Bioscience Inc. offer margin of safetyFed Meeting & Expert Verified Movement Alerts - beatles.ru
How does Harvard Bioscience Inc. compare to its peersJuly 2025 Movers & Real-Time Market Trend Scan - beatles.ru
Strategies to average down on Harvard Bioscience Inc.Market Trend Review & Free Reliable Trade Execution Plans - Newser
Is Harvard Bioscience Inc. still worth holding after the dip2025 Volume Leaders & Low Drawdown Momentum Trade Ideas - Newser
Long term hold vs stop loss in Harvard Bioscience Inc.Earnings Summary Report & Free Community Consensus Stock Picks - Newser
Can Harvard Bioscience Inc. lead its sector in growthGap Up & Reliable Breakout Stock Forecasts - خودرو بانک
Is Harvard Bioscience Inc. reversing from oversold territoryJuly 2025 Closing Moves & Precise Buy Zone Tips - Newser
Can Harvard Bioscience Inc. continue delivering strong returnsIPO Watch & Precise Buy Zone Tips - خودرو بانک
Will Harvard Bioscience Inc. benefit from macro trendsTrade Ideas & Growth Focused Entry Reports - Newser
Is Harvard Bioscience Inc. stock risky to hold nowForecast Cut & AI Enhanced Trading Signals - خودرو بانک
Is Harvard Bioscience Inc. forming a reversal pattern2025 AllTime Highs & Reliable Trade Execution Plans - Newser
Pattern recognition hints at Harvard Bioscience Inc. upsideJuly 2025 Price Swings & Accurate Intraday Trading Signals - Newser
Is Harvard Bioscience Inc. building a consolidation baseJuly 2025 Rallies & Target Return Focused Stock Picks - Newser
Can Harvard Bioscience Inc. recover in the next quarterWeekly Profit Report & Smart Money Movement Tracker - Newser
Is a relief rally coming for Harvard Bioscience Inc. holdersJuly 2025 Catalysts & Risk Controlled Stock Pick Alerts - Newser
Quantitative breakdown of Harvard Bioscience Inc. recent moveJuly 2025 Review & Weekly High Potential Alerts - Newser
Heatmap analysis for Harvard Bioscience Inc. and competitorsMarket Risk Analysis & AI Driven Price Predictions - Newser
Harvard Bioscience Inc. stock outlook for YEARWeekly Investment Summary & Real-Time Buy Zone Alerts - Newser
How to forecast Harvard Bioscience Inc. trends using time series2025 Performance Recap & Reliable Volume Spike Trade Alerts - Newser
What momentum shifts mean for Harvard Bioscience Inc.Weekly Trend Report & Free Growth Oriented Trading Recommendations - Newser
Is Harvard Bioscience Inc. showing signs of accumulation2025 Big Picture & Free Safe Capital Growth Stock Tips - Newser
Harvard Bioscience Inc. stock daily chart insightsRecession Risk & Daily Growth Stock Investment Tips - Newser
What is the long term forecast for Harvard Bioscience Inc. stockJuly 2025 Action & Free Fast Entry Momentum Trade Alerts - خودرو بانک
Published on: 2025-09-04 03:57:21 - Newser
How cyclical is Harvard Bioscience Inc.’s revenue streamEarnings Performance Report & Trade Opportunity Analysis - خودرو بانک
What earnings revisions data tells us about Harvard Bioscience Inc.Inflation Watch & Low Risk High Win Rate Picks - Newser
How moving averages guide Harvard Bioscience Inc. tradingMarket Trend Review & Real-Time Volume Analysis Alerts - Newser
Is Harvard Bioscience Inc. stock trending bullishMarket Sentiment Report & Fast Gaining Stock Reports - خودرو بانک
Detecting support and resistance levels for Harvard Bioscience Inc.July 2025 Technicals & Safe Entry Trade Reports - Newser
Institutional scanner results for Harvard Bioscience Inc.Chart Signals & High Win Rate Trade Tips - Newser
Historical volatility pattern of Harvard Bioscience Inc. visualizedEarnings Overview Report & Free Technical Pattern Based Buy Signals - Newser
Will Harvard Bioscience Inc. see short term momentumJuly 2025 Earnings & Risk Adjusted Buy and Sell Alerts - Newser
Tools to monitor Harvard Bioscience Inc. recovery probabilityRate Cut & Low Risk Growth Stock Ideas - Newser
Is this a good reentry point in Harvard Bioscience Inc.2025 Market Outlook & Weekly Top Gainers Alerts - Newser
How to recover losses in Harvard Bioscience Inc. stockBuy Signal & Free Daily Entry Point Trade Alerts - Newser
Can Harvard Bioscience Inc. be the next market leader2025 Big Picture & Fast Moving Trade Plans - خودرو بانک
Ranking Harvard Bioscience Inc. among high performing stocks via tools2025 Risk Factors & Weekly Hot Stock Watchlists - Newser
Harvard Bioscience Inc Stock (HBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):